Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer treatment pipeline.

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

Canadian Culture Minister Steven Guilbeault said Wednesday Canada needs to maximize its use of existing pipelines before ...

Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases ...

Q1 2025 Earnings Call Transcript May 13, 2025 Biodesix, Inc. reports earnings inline with expectations. Reported EPS is ...

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash ...

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

Opposition parties attacked Prime Minister Mark Carney Wednesday for being vague about his plans after his government said it ...

Dr. Lin, who is also a geriatric medicine specialist and clinical professor, testified about LECOM's track record developing ...